| CCT018159 |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000146666.4 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000152487.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000152487.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000160336.10 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000170161.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000170161.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000177406.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000177406.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000177406.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000177993.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000178193.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000178193.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000178977.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000182021.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000182165.13 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000182366.5 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000182376.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000183535.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000184068.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000185203.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000185847.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000186019.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000187904.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000188365.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000188424.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000188825.9 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000189149.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000189229.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000197462.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000197463.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000197934.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000197989.9 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000203279.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000203362.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000203441.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000203441.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000203588.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000203801.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000203865.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000203999.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000204044.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000204625.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000204791.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000204837.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000204837.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000204934.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000205054.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000205424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000205559.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000206142.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000206337.6 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000213373.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000213793.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000213963.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000213971.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000213971.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000213994.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000214146.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000214347.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000214559.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000214559.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000214719.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000214725.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000214773.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000215159.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000215256.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000215386.6 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000215424.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000215447.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000215498.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000215692.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000215863.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000215863.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000219665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000223387.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000223390.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000223393.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000223393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000223461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000223473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000223478.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000223579.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000223598.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000223598.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000223695.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000223701.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000223714.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000223751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000223768.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000223784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000223791.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000223799.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000223811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000223949.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000223949.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000224046.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000224174.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000224260.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000224267.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000224271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000224276.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000224292.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000224342.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000224424.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000224441.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000224460.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000224468.3 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000224481.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000224490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000224536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000224574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000224592.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000224596.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000224616.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000224621.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000224623.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000224635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000224638.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000224660.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000224691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000224817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000224844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000224844.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000224855.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000224855.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000224959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000224959.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000225039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000225039.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000225077.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000225087.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000225173.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000225187.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000225234.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000225300.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000225302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000225302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000225335.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000225335.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000225342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000225353.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000225434.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000225442.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000225595.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000225611.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000225703.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000225744.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000225793.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000225836.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000225914.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000225953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000226007.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000226017.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000226026.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000226101.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000226125.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000226200.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000226200.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000226258.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000226281.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000226328.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000226332.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000226377.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000226386.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000226419.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000226476.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000226609.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000226649.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000226661.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000226684.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000226688.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000226747.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000226752.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000226754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000226803.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000226824.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000226824.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000226899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000226900.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000226919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000227006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000227039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000227070.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000227070.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000227071.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000227076.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000227107.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000227117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000227161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000227161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000227165.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000227186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000227188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000227192.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000227214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000227215.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000227218.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000227359.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000227373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000227375.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000227388.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000227456.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000227492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000227492.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000227495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000227518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000227533.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000227543.3 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000227619.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000227627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000227704.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000227740.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000227773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000227857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000227857.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000227954.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000227959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000228037.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000228113.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000228115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000228126.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000228137.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000228139.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000228192.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000228242.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000228242.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000228274.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000228288.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000228293.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000228293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000228327.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000228352.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000228352.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000228386.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000228485.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000228548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000228614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000228624.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000228629.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000228639.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000228639.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000228661.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000228661.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000228677.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000228677.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000228686.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000228705.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000228718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000228737.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000228748.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000228748.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000228786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000228801.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000228812.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000228817.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000228838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000228886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000229017.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000229021.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000229043.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000229118.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000229118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000229162.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000229190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000229195.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000229227.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000229368.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000229400.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000229404.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000229404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000229431.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000229491.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000229525.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000229539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000229591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000229621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000229739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000229751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000229839.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000229847.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000229869.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000229950.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000229951.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000229952.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000230021.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000230046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000230063.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000230084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000230105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000230290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000230316.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000230345.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000230368.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000230381.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000230487.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000230530.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000230561.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000230649.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000230699.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000230731.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000230753.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000230817.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000230881.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000230896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000231013.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000231024.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000231028.4 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000231039.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000231119.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000231212.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000231233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000231233.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000231290.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000231305.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000231324.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000231563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000231651.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000231652.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000231728.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000231760.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000231769.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000231770.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000231795.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000231806.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000231851.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000231856.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000231890.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000231908.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000231908.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000231927.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000231977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000231993.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000231999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000232028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000232034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000232110.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000232184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000232233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000232290.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000232311.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000232311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000232311.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000232490.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000232504.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000232519.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000232527.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000232533.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000232533.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000232593.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000232600.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000232623.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000232640.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000232693.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000232712.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000232725.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000232811.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000232860.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000232876.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000232995.3 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000233058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000233077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000233117.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000233144.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000233184.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000233184.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000233203.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000233250.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000233250.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000233296.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000233334.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000233334.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000233368.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000233429.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000233452.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000233483.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000233515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000233547.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000233613.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000233621.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000233635.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000233672.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000233705.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000233754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000233757.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000233817.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000233825.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000233903.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000233930.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000233953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000233967.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000233977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000234206.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000234210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000234252.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000234263.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000234323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000234405.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000234494.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000234509.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000234509.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000234571.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000234650.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000234665.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000234676.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000234690.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000234695.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000234741.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000234793.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000234793.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000234817.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000234848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000234899.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000234915.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000234917.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000234943.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000234945.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000234945.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000234996.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000235033.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000235052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000235052.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000235096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000235100.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000235117.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000235204.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000235215.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000235245.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000235257.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000235269.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000235313.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000235319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000235326.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000235335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000235381.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000235381.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000235397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000235423.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000235488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000235493.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000235522.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000235527.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000235527.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000235560.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000235590.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000235635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000235652.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000235664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000235664.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000235795.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000235802.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000235823.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000235831.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000235834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000235934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000236003.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000236003.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000236024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000236031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000236091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236095.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000236098.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000236166.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000236173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000236194.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000236200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000236209.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000236213.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236255.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000236255.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000236256.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000236308.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000236308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000236393.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000236423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000236432.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000236494.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000236498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000236528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000236528.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000236537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236537.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000236548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000236641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236724.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000236743.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000236772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000236810.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000236850.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000236869.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000236914.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000236947.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000236953.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000237021.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000237021.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000237037.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000237152.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000237181.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000237200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000237248.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000237253.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000237311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000237343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000237343.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000237356.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000237357.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000237481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000237485.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000237485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000237485.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000237505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000237512.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000237548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000237605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000237646.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000237689.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000237737.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000237768.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000237803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000237813.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000237857.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000237883.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000237892.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000237921.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000237934.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000237938.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000237950.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000237998.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000238120.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000238120.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000238164.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000238221.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000239213.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000239213.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000239219.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000239377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000239415.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000239462.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000239482.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000239498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000239636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000239911.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000239921.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000240032.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000240050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000240350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000240373.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000240401.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000240453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000240499.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000240553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000240591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000240618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000240766.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000240875.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000240895.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000241048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000241135.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000241168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000241180.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000241180.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000241211.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000241472.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000241570.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000241593.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000241599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000241764.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000242042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000242078.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000242125.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000242349.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000242474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000242687.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000242791.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000242902.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000243144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000243150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000243176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000243193.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000243350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000243389.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000243415.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000243415.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000243433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000243485.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000243491.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000243797.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000244040.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000244286.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000244286.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000244349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000244380.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000244586.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000244675.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000244676.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000244968.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000244968.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000245105.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000245148.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000245468.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000245534.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000245534.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000245573.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000245648.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000245768.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000246145.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000246263.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000246273.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000246273.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000246308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000246323.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000246523.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000246740.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000246740.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000246863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000247095.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000247151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000247287.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000247311.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000247363.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000247363.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000247400.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000247498.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000247556.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000247708.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000247735.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000247796.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000247796.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000247809.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000247853.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000247877.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000248027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000248092.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000248100.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000248161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000248161.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000248307.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000248367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000248388.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000248399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000248429.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000248508.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000248514.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000248538.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000248559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000248576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000248599.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000248698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000248787.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000248858.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000248925.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000248932.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000249207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000249216.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000249279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000249309.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000249348.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000249356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000249379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000249395.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000249412.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000249476.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000249492.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000249572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000249602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000249637.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000249669.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000249690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000249713.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000249753.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000249846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000249868.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000249894.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000249942.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000249996.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000249996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000249996.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000250012.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000250012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000250027.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000250061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000250073.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000250081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000250116.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000250122.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000250122.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000250156.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000250195.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000250198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000250241.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000250326.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000250337.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000250337.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000250378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000250409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000250451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000250635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000250748.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000250765.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000250802.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000250909.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000250917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000250938.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000250990.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000250999.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000251003.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000251003.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000251022.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000251023.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000251034.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000251072.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000251131.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000251175.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000251179.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000251194.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000251194.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000251221.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000251257.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000251298.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000251307.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000251350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000251379.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000251409.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000251513.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000251556.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000251600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000251602.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000251613.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000251675.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000253112.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000253174.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000253174.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000253282.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000253347.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000253361.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000253372.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000253390.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000253392.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000253475.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000253618.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000253618.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000253636.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000253636.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000253666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000253669.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000253678.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000253695.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000253744.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000253754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000253773.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000253825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000253848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000253878.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000253917.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000253917.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000253929.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000253948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000253955.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000253982.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000253982.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000254003.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000254094.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000254101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254144.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000254144.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000254165.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000254207.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000254207.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000254208.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000254224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000254231.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000254258.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000254353.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000254362.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254362.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000254389.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000254427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000254444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000254461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000254468.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000254468.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000254480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000254480.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000254542.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000254604.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000254607.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254615.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000254631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254693.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000254699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254718.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000254756.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000254762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254762.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000254791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000254833.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000254847.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000254854.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000254859.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000254859.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000254929.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000254934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000254988.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000255031.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000255045.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000255080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255094.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000255100.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000255139.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000255165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255247.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255299.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000255306.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000255306.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000255326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000255409.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000255421.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000255434.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000255443.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000255474.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000255495.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000255521.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000255651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000255741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000255790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000255790.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255857.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000255886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000255893.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000256011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000256050.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000256083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000256237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000256250.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000256299.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000256650.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000256742.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000256746.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000256751.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000256955.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000256973.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000257004.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000257004.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000257027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000257038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000257052.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000257052.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000257058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000257135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257137.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000257139.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000257222.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000257261.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000257264.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257270.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000257270.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000257279.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000257283.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000257329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000257337.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000257391.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000257433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000257488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000257496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257497.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000257515.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000257526.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000257534.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000257543.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000257613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257636.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000257681.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000257711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257759.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000257815.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000257877.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000257890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000257913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000257953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257953.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000257999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000257999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000258017.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000258057.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000258082.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000258099.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000258099.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000258122.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000258181.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000258240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000258303.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000258323.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000258325.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000258343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000258378.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000258378.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000258428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000258443.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000258449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000258454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000258458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000258521.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000258526.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000258553.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000258623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000258663.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000258704.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000258752.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000258821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000258821.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000258851.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000258858.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000258914.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000258920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000258929.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000258999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259001.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000259031.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000259088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000259209.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259219.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000259275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000259294.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000259343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000259349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000259366.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000259377.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000259408.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000259418.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000259424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000259426.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000259442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000259448.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000259469.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259469.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000259475.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000259483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259499.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000259521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000259521.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000259540.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259606.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000259682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259694.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000259694.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000259709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000259712.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000259719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259758.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000259768.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000259771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000259793.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000259799.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000259802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000259802.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000259804.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000259806.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000259810.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000259865.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000259888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000259899.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000259933.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000259943.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000259974.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260000.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000260011.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000260018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000260025.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000260046.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260052.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000260059.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000260081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000260083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000260086.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000260093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000260136.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000260167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000260231.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000260257.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000260260.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000260281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000260329.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000260336.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260349.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000260423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000260436.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000260440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000260475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000260498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000260528.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000260542.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000260572.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260585.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000260592.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000260693.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000260708.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000260708.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000260743.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000260743.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000260773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000260777.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000260810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000260814.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260823.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000260830.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000260833.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000260841.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260853.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000260855.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000260874.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000260874.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000260877.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000260920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000260936.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000260941.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000260941.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000260948.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260948.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000260953.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000260977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000260978.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000260996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000261015.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261019.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261039.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000261051.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000261051.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000261122.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000261135.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000261168.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000261170.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000261172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000261191.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000261242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000261251.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000261252.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261253.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000261265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000261286.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000261337.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000261341.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000261360.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261366.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000261366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000261367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000261392.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000261392.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000261433.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000261437.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000261460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000261468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000261469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000261476.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000261481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000261485.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000261485.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261488.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000261505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000261529.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000261542.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000261544.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000261550.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000261574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000261589.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000261595.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000261662.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261673.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000261716.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000261723.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000261744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000261754.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000261760.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000261766.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000261775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000261775.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000261775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000261798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000261804.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000261824.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000261829.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000261879.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000261889.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000261889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000261916.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000261916.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000261924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000262098.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000262099.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000262171.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000262172.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000262185.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000262185.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000262185.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000262194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000262222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000262319.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000262362.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000262514.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000262662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000262663.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000262681.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000262721.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000262766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000262786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000262823.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000262873.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000262877.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000262879.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000262951.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000262952.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000263004.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000263013.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000263069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000263105.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000263164.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000263214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000263280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000263350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000263393.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000263393.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000263470.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000263531.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000263624.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000263847.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000263860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000263884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000263916.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000263982.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000264026.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000264031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000264235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000264513.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000264569.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000264672.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000264808.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000264808.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000264860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000264885.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000264920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000264964.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000264964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000265008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000265010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000265185.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000265206.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000265337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000265342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000265394.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000265458.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000265688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000265728.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000265739.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000265749.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000265750.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000265778.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000265778.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000265791.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000265799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000265845.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000266111.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000266126.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000266236.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000266278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000266283.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000266289.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000266311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000266371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000266401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000266538.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000266541.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000266654.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000266709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000266717.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000266783.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000266801.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000266896.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000266900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000266900.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000266912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000266916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000266933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000266969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000266969.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000266970.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000267000.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000267015.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000267018.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000267039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267052.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000267064.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000267064.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000267112.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000267115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267117.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267121.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000267131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000267138.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000267159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000267174.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000267183.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267192.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000267230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267274.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000267289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000267298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000267322.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000267327.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000267342.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000267344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000267345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000267374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267390.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000267405.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000267432.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000267437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000267498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267519.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000267522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267530.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000267539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267539.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000267549.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000267550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267557.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000267586.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267606.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000267655.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000267751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000267751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267761.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000267778.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000267798.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000267804.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000267834.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000267858.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000267886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000268049.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000268095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000268186.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000268289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000268333.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000268362.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000268366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000268520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000268530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000268573.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000268601.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000268605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000268605.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000268613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000268743.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000268812.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000268912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000268913.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000268947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000269194.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000269321.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000269386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000269397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000269444.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000269463.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000269483.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000269486.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000269487.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000269487.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000269534.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000269535.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000269646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000269680.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000269737.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000269825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000269836.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000269895.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000269899.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000269901.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000269923.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000269947.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000269956.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000269967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000269974.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000269978.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000269983.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000269985.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000270000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000270001.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000270006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000270006.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000270009.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000270015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000270036.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000270041.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000270050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000270055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000270067.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000270068.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000270072.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000270076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000270083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000270095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000270100.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000270104.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000270104.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000270110.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000270124.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000270157.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000270195.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000270246.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000270265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000270332.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000270346.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000270346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000270361.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000270362.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000270462.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000270482.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000270607.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000270673.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000270673.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000270720.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000270876.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000270949.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000270949.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000271020.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000271086.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000271172.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000271185.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000271204.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000271204.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000271228.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000271327.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000271359.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000271401.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000271401.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000271555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000271590.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000271717.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000271732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000271751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000271755.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000271778.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000271803.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000271840.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000271840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000271843.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000271856.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000271862.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000271912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000271913.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000271914.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000271930.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000271967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000271973.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000271993.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000272004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272010.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000272023.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000272030.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000272033.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272053.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000272097.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272102.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272137.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000272138.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000272140.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000272142.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000272183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272219.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000272221.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272225.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000272226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000272273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272320.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272360.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272361.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272368.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000272375.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000272382.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000272384.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272389.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000272416.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000272432.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000272432.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272438.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272440.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000272485.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000272505.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000272508.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000272525.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272558.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000272576.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000272622.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000272627.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000272662.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272663.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272689.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000272691.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000272721.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272744.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000272755.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272777.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272784.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000272787.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000272799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272810.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272825.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272828.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272853.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000272858.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272861.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT018159 |
ENSG00000272888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000272894.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000272902.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000272940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000272942.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000272945.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000272960.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000272979.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000272984.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000272993.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000273008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000273014.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000273017.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000273018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000273026.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000273038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000273038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000273056.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT018159 |
ENSG00000273059.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000273061.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000273066.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000273091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000273108.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000273117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT018159 |
ENSG00000273117.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000273117.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000273118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000273137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000273142.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000273162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000273165.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000273179.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| CCT018159 |
ENSG00000273181.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT018159 |
ENSG00000273183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000273249.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000273253.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000273257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000273297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000273302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000273311.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000273329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000273335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000273342.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000273343.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000273350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT018159 |
ENSG00000273350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000273353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT018159 |
ENSG00000273365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT018159 |
ENSG00000273366.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT018159 |
ENSG00000273381.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT018159 |
ENSG00000273416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000273424.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT018159 |
ENSG00000273428.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT018159 |
ENSG00000273443.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT018159 |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT018159 |
ENSG00000273449.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| CCT018159 |
ENSG00000273486.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|